Conavi Medical Insider Trading
TSX-V CNVI
1
All Trades
1
Significant
0
Notable
0
Clusters
0
Repeat
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| Conavi Medical | ██████ | ████████ | ██-███-26 | ███,███ | $█.██ | $███,███ | ███,███ | ██% | ████████ |
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| Conavi Medical | Cpoint Capital | 10% Shareholder | 23-Apr-25 | 625,000 | $0.40 | $250,000 | 2,035,955 | 44% | Significant |
Stock Chart
Related Companies to Explore
Company Info
Conavi Medical is a Canadian medical technology company that develops intravascular imaging systems for cardiovascular procedures. The company operates primarily in North America and Europe, focusing on providing advanced imaging solutions to help physicians diagnose and treat coronary artery disease. Their flagship product is the Novasight Hybrid System, which combines optical coherence tomography and intravascular ultrasound technologies into a single catheter-based imaging platform. This system allows cardiologists to obtain detailed, real-time images of blood vessels during cardiac catheterization procedures, helping them make more informed treatment decisions. The company’s technology aims to improve patient outcomes by providing clearer visualization of arterial blockages and vessel conditions compared to traditional imaging methods. Conavi Medical has received regulatory approvals in multiple markets, including Health Canada and CE marking in Europe. The company was founded in 2010 and is headquartered in Toronto, Ontario. Their imaging systems are designed to be compatible with existing cardiac catheterization laboratory equipment, making adoption easier for hospitals and medical centers. The company continues to develop additional applications for its core imaging technology platform.